Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Asset Utilization Ratio (2021 - 2025)

Mirum Pharmaceuticals has reported Asset Utilization Ratio over the past 5 years, most recently at 0.64 for Q4 2025.

  • Quarterly results put Asset Utilization Ratio at 0.64 for Q4 2025, up 27.25% from a year ago — trailing twelve months through Dec 2025 was 0.64 (up 27.25% YoY), and the annual figure for FY2025 was 0.69, up 34.69%.
  • Asset Utilization Ratio for Q4 2025 was 0.64 at Mirum Pharmaceuticals, up from 0.62 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for MIRM hit a ceiling of 0.64 in Q4 2025 and a floor of 0.05 in Q2 2021.
  • Median Asset Utilization Ratio over the past 5 years was 0.29 (2023), compared with a mean of 0.32.
  • Biggest five-year swings in Asset Utilization Ratio: skyrocketed 197.44% in 2022 and later rose 23.64% in 2024.
  • Mirum Pharmaceuticals' Asset Utilization Ratio stood at 0.07 in 2021, then skyrocketed by 197.44% to 0.21 in 2022, then soared by 33.72% to 0.29 in 2023, then skyrocketed by 75.17% to 0.5 in 2024, then increased by 27.25% to 0.64 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.64 (Q4 2025), 0.62 (Q3 2025), and 0.61 (Q2 2025) per Business Quant data.